|
|
Volumn 1, Issue 2, 2005, Pages 111-117
|
|
Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
ANTITHROMBOCYTIC AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ATHEROSCLEROSIS;
ESTROGEN THERAPY;
FEMALE;
HUMAN;
PATHOPHYSIOLOGY;
PERIPHERAL VASCULAR DISEASE;
PREVALENCE;
REVIEW;
RISK FACTOR;
SEX DIFFERENCE;
SEX RATIO;
TREATMENT OUTCOME;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTILIPEMIC AGENTS;
ATHEROSCLEROSIS;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
HUMANS;
PERIPHERAL VASCULAR DISEASES;
PLATELET AGGREGATION INHIBITORS;
PREVALENCE;
RISK FACTORS;
SEX DISTRIBUTION;
SEX FACTORS;
TREATMENT OUTCOME;
|
|
EID: 33947514527
PISSN: 11766344
EISSN: None
Source Type: Journal
DOI: 10.2147/vhrm.1.2.111.64084 Document Type: Review |
|
Times cited : (9)
|
|
References (43)
|
